Intrinsic Value of S&P & Nasdaq Contact Us

AMN Healthcare Services, Inc. AMN NYSE

NYSE • Healthcare • Medical - Care Facilities • US • USD

SharesGrow Score
39/100
1/7 Pass
SharesGrow Intrinsic Value
$91.08
+385%
Analyst Price Target
$22.88
+21.8%

AMN Healthcare Services, Inc. (AMN) is a Medical - Care Facilities company in the Healthcare sector, currently trading at $18.78. It has a SharesGrow Score of 39/100, indicating a weak investment profile with 1 out of 7 criteria passed.

SharesGrow calculates the intrinsic value of AMN = $91.08 (+385% from the current price, the stock appears undervalued). Analyst consensus target is AMN = $23 (+21.8% upside).

Valuation: AMN trades at a trailing Price-to-Earnings (P/E) of -7.5 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.17.

Financials: revenue is $2.7B, -19.2%/yr average growth. Net income is $96M (loss), growing at -62.5%/yr. Net profit margin is -3.5% (negative). Gross margin is 22.9% (-9.8 pp trend).

Balance sheet: total debt is $803M against $642M equity (Debt-to-Equity (D/E) ratio 1.25, moderate). Current ratio is 0.94 (tight liquidity). Debt-to-assets is 38.4%. Total assets: $2.1B.

Analyst outlook: 10 / 17 analysts rate AMN as buy (59%) — moderate consensus.

SharesGrow 7-Criteria breakdown: Value 90/100 (Pass), Growth 15/100 (Fail), Past 50/100 (Partial), Health 17/100 (Fail), Moat 32/100 (Fail), Future 58/100 (Partial), Income 10/100 (Fail).

$22.88
▲ 21.83% Upside
Average Price Target
Based on 17 Wall Street analysts offering 12-month price targets for AMN Healthcare Services, Inc., the average price target is $22.88, with a high forecast of $25.00, and a low forecast of $19.50.
Highest Price Target
$25.00
Average Price Target
$22.88
Lowest Price Target
$19.50

AMN SharesGrow Score Overview

39/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
VALUE 90/100
Valuation — P/E, PEG, Forward PEG
GROWTH 15/100
Financials — average growth
PAST 50/100
strong — trend
HEALTH 17/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 32/100
Gross margin is + market cap
FUTURE 58/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — AMN

VALUE Pass
90/100
AMN trades at a trailing Price-to-Earnings (P/E) of -7.5 (S&P 500 average ~25). Forward PEG 0.17 — Peter Lynch undervalued (≤1.0). Analyst consensus target is $23, implying +22.5% from the current price $19. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
GROWTH Fail
15/100
AMN: -19.2%/yr revenue is, -62.5%/yr Net income is average growth. weak. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
~
PAST Partial
50/100
AMN: 2 / 4 years profitable. weak. Score = 2 / 4 × 100. ≥ 80 = Pass.
View details →
HEALTH Fail
17/100
Balance sheet AMN: Debt-to-Equity (D/E) ratio 1.25 (moderate), Current ratio is 0.94 (tight liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
MOAT Fail
32/100
AMN: Gross margin is 22.9% (-9.8 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 32/100. ≥ 70 = Pass.
View details →
~
FUTURE Partial
58/100
Analyst outlook: 10 / 17 analysts rate AMN as buy (59%). Analyst consensus target is $23 (+22.5% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
INCOME Fail
10/100
AMN: Net profit margin is -3.5%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range14.87-23.74
Volume463.03K
Avg Volume (30D)1.3M
Market Cap$725.68M
Beta (1Y)0.25
Share Statistics
EPS (TTM)-2.48
Shares Outstanding$38.52M
IPO Date2001-11-13
Employees2,968
CEOCaroline Sullivan Grace
Financial Highlights & Ratios
Revenue (TTM)$2.73B
Gross Profit$626.19M
EBITDA$101.13M
Net Income$-95.7M
Operating Income$33.17M
Total Cash$33.97M
Total Debt$803.2M
Net Debt$769.23M
Total Assets$2.09B
Price / Earnings (P/E)-7.6
Price / Sales (P/S)0.27
Analyst Forecast
1Y Price Target$23.50
Target High$25.00
Target Low$19.50
Upside+25.1%
Rating ConsensusBuy
Analysts Covering17
Buy 59% Hold 35% Sell 6%
Price Target Summary
Company Info
CountryUS
ExchangeNYSE
CurrencyUSD
ISINUS0017441017

Price Chart

AMN
AMN Healthcare Services, Inc.  ·  NYSE
Healthcare • Medical - Care Facilities
14.87 52WK RANGE 23.74
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message